Stockscreener 앱 받기
35.82
0.00%
0.00
시간 외 거래:
36.00
0.18
+0.50%
전일 마감가:
$35.82
열려 있는:
$35.93
하루 거래량:
570.48K
Relative Volume:
0.45
시가총액:
$8.18B
수익:
$5.30B
순이익/손실:
$-624.00M
주가수익비율:
-11.67
EPS:
-3.0692
순현금흐름:
$42.00M
1주 성능:
+4.43%
1개월 성능:
-10.47%
6개월 성능:
-18.59%
1년 성능:
-44.43%
1일 변동 폭
$35.59
$36.64
1주일 범위
$34.09
$36.64
52주 변동 폭
$32.45
$65.57
Lineage Inc Stock (LINE) Company Profile
명칭
Lineage Inc
전화
(800) 678-7271
주소
46500 HUMBOLDT DRIVE, NOVI
LINE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
35.82 | 8.18B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
128.53 | 119.04B | 8.74B | 3.43B | 4.27B | 3.4347 |
|
PSA
Public Storage
|
274.54 | 48.11B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
133.17 | 28.29B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
REXR
Rexford Industrial Realty Inc
|
41.61 | 9.70B | 903.94M | 275.97M | 94.31M | 1.23 |
|
EGP
Eastgroup Properties Inc
|
181.18 | 9.67B | 679.77M | 236.60M | 385.49M | 4.6371 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-07-01 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-06-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | 다운그레이드 | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | 개시 | Citigroup | Neutral |
| 2025-01-14 | 개시 | Exane BNP Paribas | Neutral |
| 2024-12-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-09-18 | 개시 | CapitalOne | Overweight |
| 2024-09-16 | 개시 | CapitalOne | Overweight |
| 2024-08-19 | 개시 | Deutsche Bank | Hold |
| 2024-08-19 | 개시 | Evercore ISI | In-line |
| 2024-08-19 | 개시 | Goldman | Buy |
| 2024-08-19 | 개시 | JP Morgan | Overweight |
| 2024-08-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | 개시 | Mizuho | Neutral |
| 2024-08-19 | 개시 | Morgan Stanley | Overweight |
| 2024-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-08-19 | 개시 | Robert W. Baird | Outperform |
| 2024-08-19 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 개시 | Truist | Buy |
| 2024-08-19 | 개시 | UBS | Neutral |
| 2024-08-19 | 개시 | Wells Fargo | Equal Weight |
모두보기
Lineage Inc 주식(LINE)의 최신 뉴스
How Investors May Respond To Lineage (LINE) Expanding Automated Cold Storage and Global Logistics Capabilities - simplywall.st
Will Lineage Inc. stock maintain growth storyTrade Entry Report & Long-Term Safe Investment Ideas - moha.gov.vn
Lineage Therap Withdraws CIRM Grant Application - TipRanks
Lineage Cell Therapeutics Inc withdrew CIRM grant application filed in June 2025SEC filing - MarketScreener
Lineage Cell Therapeutics Withdraws CIRM Grant Application - TradingView
Lineage Cell Therapeutics (LCTX) pulls CIRM CLIN2 grant application, plans OPC1 resubmission - Stock Titan
A Closer Look at Lineage (LINE) Valuation Following Recent Share Price Swings - simplywall.st
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Does Lineage Inc. stock trade at a discount to peersMarket Rally & Technical Confirmation Trade Alerts - moha.gov.vn
Pension funds sue Morgan Stanley, Goldman over misleading $5B Lineage IPO - InvestmentNews
LINEAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Securities Class Action LawsuitLINE (PR Newswire) - Aktiellt
LINEAGE INVESTOR ALERT: Investor Files Class Action Lawsuit Against Lineage, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Investor Class Action LawsuitLINE (PR Newswire) - Aktiellt
LINEAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Investor Class Action LawsuitLINE (PR Newswire) - Aktiellt
Wells Fargo Keeps Their Hold Rating on Lineage, Inc. (LINE) - The Globe and Mail
Is Lineage Stock a Buy? Pennington Partners Opens New $3 Million Position in the Company - Nasdaq
Goldman Sachs Maintains Lineage (LINE) Buy Recommendation - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Investors to Connect - ACCESS Newswire
Lineage breaks ground on automated cold storage facility in Texas - MEAT+POULTRY
Lineage, Inc. Sees Major Investment from Top Executive! - TipRanks
[Form 4] Lineage, Inc. Insider Trading Activity - Stock Titan
Latham & Watkins Represents Lineage in €700 Million Senior Notes Offering - Legal Desire Media and Insights
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lineage subsidiary proposes euro-denominated notes offering - MSN
Are you ready to seize new market opportunities with Lineage Inc. after the White House tariff rollback? - DC Velocity
Lineage Breaks Ground on New Automated Facility in Dallas Market; Tim Smith, Mario Vasquez, and More Comment - Deli Market News
First Week of July 2026 Options Trading For Lineage (LINE) - Nasdaq
Why Lineage Cell Therapeutics Inc. stock is popular among millennialsTrade Risk Assessment & Daily Risk Controlled Trade Plans - newser.com
Will Lineage Cell Therapeutics Inc. stock test record highs in 20252025 Support & Resistance & Risk Managed Investment Strategies - newser.com
Lineage Inc: Intends to Use Net Proceeds to R - 富途牛牛
Lineage Stands Ready to Help Customers Seize Market Opportunities as Tariffs on Food Products Roll Back - Business Wire
Automated Cold Storage Expansion Could Be a Game Changer for Lineage (LINE) - simplywall.st
Lineage subsidiary prices €700 million senior notes offering By Investing.com - Investing.com Australia
Why Lineage Cell Therapeutics Inc. stock could see breakout soon2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock expanding market penetrationTrade Analysis Report & Momentum Based Trading Ideas - newser.com
How Lineage Cell Therapeutics Inc. stock reacts to oil pricesPortfolio Return Report & Entry and Exit Point Strategies - newser.com
Is it time to cut losses on Lineage Inc.Dip Buying & Fast Gain Stock Tips - newser.com
When is the best time to exit Lineage Inc.2025 AllTime Highs & Verified Short-Term Plans - newser.com
What dividend safety score for Lineage Inc. stockMarket Trend Report & Weekly Market Pulse Alerts - newser.com
Lineage Inc. stock chart pattern explainedMarket Risk Analysis & AI Driven Price Predictions - newser.com
Is Lineage Cell Therapeutics Inc. stock a momentum leader - newser.com
How Lineage Inc. stock performs in interest rate cyclesJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Lineage subsidiary prices €700 million senior notes offering - Investing.com India
Lineage, Inc. Prices €700M Senior Notes Offering - TipRanks
[8-K] Lineage, Inc. Reports Material Event | LINE SEC FilingForm 8-K - Stock Titan
Lineage Announces Pricing of €700 million of Senior Notes due 2031 - Bluefield Daily Telegraph
How strong is Lineage Inc. stock balance sheetEntry Point & High Return Stock Watch Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Is Lineage Cell Therapeutics Inc. stock a buy before product launchesJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
Technical analysis overview for Lineage Inc. stockVolume Spike & Fast Exit Strategy with Risk Control - newser.com
Lineage breaks ground on new automated facility in Dallas market - The Produce News
Lineage, Inc. (LINE) Tops Q3 FFO and Revenue Estimates - MSN
Lineage Inc (LINE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lineage Inc 주식 (LINE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LeMasters Robb A. | Chief Financial Officer |
Nov 13 '25 |
Buy |
33.74 |
30,000 |
1,012,197 |
60,000 |
| Forste Adam Matthew Schwartz | Co-Executive Chairman |
Nov 10 '25 |
Buy |
33.83 |
74,000 |
2,503,250 |
109,266 |
| Marchetti Kevin Patrick | Co-Executive Chairman |
Nov 10 '25 |
Buy |
33.72 |
14,500 |
489,010 |
89,168 |
| Crisci Robert | Chief Financial Officer |
Nov 07 '25 |
Buy |
34.56 |
10,000 |
345,630 |
107,859 |
| Marchetti Kevin Patrick | Co-Executive Chairman |
Aug 19 '25 |
Buy |
40.44 |
12,345 |
499,254 |
74,668 |
| Thattai Sudarsan V | See Remarks |
Aug 08 '25 |
Buy |
42.45 |
3,563 |
151,238 |
7,983 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
Aug 08 '25 |
Buy |
42.28 |
23,540 |
995,216 |
62,323 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 09 '25 |
Buy |
45.63 |
11,050 |
504,187 |
38,783 |
| Forste Adam Matthew Schwartz | CO-EXECUTIVE CHAIRMAN |
May 08 '25 |
Buy |
44.93 |
10,949 |
491,921 |
35,266 |
| Marchetti Kevin Patrick | CO-EXECUTIVE CHAIRMAN |
May 06 '25 |
Buy |
43.75 |
11,500 |
503,074 |
27,733 |
0.32%
0.00%
자본화:
|
볼륨(24시간):